Q2 Earnings Forecast for THC Issued By Leerink Partnrs

Tenet Healthcare Co. (NYSE:THC - Free Report) - Investment analysts at Leerink Partnrs decreased their Q2 2025 earnings per share (EPS) estimates for Tenet Healthcare in a report issued on Wednesday, February 12th. Leerink Partnrs analyst W. Mayo now anticipates that the company will earn $2.60 per share for the quarter, down from their prior forecast of $2.66. The consensus estimate for Tenet Healthcare's current full-year earnings is $11.37 per share. Leerink Partnrs also issued estimates for Tenet Healthcare's Q4 2025 earnings at $3.43 EPS, Q1 2026 earnings at $3.46 EPS, Q2 2026 earnings at $3.27 EPS, Q3 2026 earnings at $3.08 EPS, Q4 2026 earnings at $3.83 EPS, FY2028 earnings at $25.45 EPS and FY2029 earnings at $28.57 EPS.

THC has been the topic of several other research reports. UBS Group upped their price objective on Tenet Healthcare from $197.00 to $217.00 and gave the stock a "buy" rating in a research report on Wednesday, October 30th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $177.00 target price on shares of Tenet Healthcare in a research note on Thursday, February 13th. Wells Fargo & Company downgraded Tenet Healthcare from an "overweight" rating to an "equal weight" rating and reduced their target price for the stock from $205.00 to $150.00 in a research note on Monday, November 25th. StockNews.com downgraded Tenet Healthcare from a "buy" rating to a "hold" rating in a research note on Thursday, February 13th. Finally, The Goldman Sachs Group downgraded Tenet Healthcare from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $196.00 to $140.00 in a research note on Monday, December 16th. Four equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $163.19.

Tenet Healthcare Stock Performance

Tenet Healthcare stock traded up $1.99 during mid-day trading on Friday, hitting $135.30. The company had a trading volume of 1,940,298 shares, compared to its average volume of 1,272,913. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 2.35. Tenet Healthcare has a 12-month low of $88.98 and a 12-month high of $171.20. The company's fifty day moving average is $133.09 and its 200-day moving average is $147.95. The company has a market capitalization of $12.87 billion, a price-to-earnings ratio of 4.34, a P/E/G ratio of 0.63 and a beta of 2.05.

Tenet Healthcare (NYSE:THC - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, topping the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a return on equity of 24.05% and a net margin of 14.91%.

Hedge Funds Weigh In On Tenet Healthcare

A number of hedge funds have recently modified their holdings of the business. Coldstream Capital Management Inc. grew its holdings in shares of Tenet Healthcare by 2.2% during the 3rd quarter. Coldstream Capital Management Inc. now owns 3,406 shares of the company's stock worth $566,000 after purchasing an additional 74 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in Tenet Healthcare by 9.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 940 shares of the company's stock valued at $119,000 after acquiring an additional 80 shares during the period. GeoWealth Management LLC boosted its holdings in Tenet Healthcare by 39.8% during the 4th quarter. GeoWealth Management LLC now owns 295 shares of the company's stock valued at $37,000 after acquiring an additional 84 shares during the period. Spire Wealth Management boosted its holdings in Tenet Healthcare by 19.5% during the 4th quarter. Spire Wealth Management now owns 558 shares of the company's stock valued at $70,000 after acquiring an additional 91 shares during the period. Finally, CIBC Private Wealth Group LLC boosted its holdings in Tenet Healthcare by 1.7% during the 4th quarter. CIBC Private Wealth Group LLC now owns 5,619 shares of the company's stock valued at $732,000 after acquiring an additional 92 shares during the period. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.